Show simple item record

dc.contributor.authorBhuju, Sabin
dc.contributor.authorFonseca, Leila de Souza
dc.contributor.authorMarsico, Anna Grazia
dc.contributor.authorde Oliveira Vieira, Gisele Betzler
dc.contributor.authorSobral, Luciana Fonseca
dc.contributor.authorStehr, Matthias
dc.contributor.authorSingh, Mahavir
dc.contributor.authorSaad, Maria Helena Féres
dc.date.accessioned2013-08-15T13:28:21Z
dc.date.available2013-08-15T13:28:21Z
dc.date.issued2013-06-14
dc.identifier.citationMycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene. 2013, 19C:1-6 Infect. Genet. Evol.en_GB
dc.identifier.issn1567-7257
dc.identifier.pmid23770140
dc.identifier.doi10.1016/j.meegid.2013.06.008
dc.identifier.urihttp://hdl.handle.net/10033/298902
dc.description.abstractIt has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosis is correlated with mutations in the pncA gene. But since years researchers have been puzzled by the fact that up to 30% of PZA resistant strains do not show any correlation between PZA resistance and mutations in the pncA gene, and thus may vary with geographic area. The objective of the study was to investigate the correlation between PZA susceptibility and mutations in pncA gene in M. tuberculosis isolates from individuals living in a highly endemic area. Therefore we analyzed drug resistant and multidrug resistant (MDR) isolates from patients in Rio de Janeiro, Brazil. From a total of 97 clinical isolates of M. tuberculosis 35 were identified as PZA resistant, 24/35 strains did not show PZase activity and 15/24 (62.5%) strains possess mutation in the pncA gene. This is a low correlation between PZA resistance and PZase activity (68.6%) and even lower correlation between PZA resistance and the presence of mutation in pncA gene (45.7%). Most of the mutations found were conserved near the active site or metal binding site of PZase. The 146A>C mutation was found both in PZA resistant and susceptible isolates, suggesting that this mutation may not fully associated with PZA resistance. Of the mutations found, three have not been previously described. The insertions 192-193 TCCTCGTC and 388-389 AGGTCGATG, although found before, here was found to be a short tandem repeat and in one strain, insertion of the IS6110 was observed 55nt upstream of the gene. All PZA resistant isolates had no mutation in the gene coding ribosomal protein S1 (rpsA), which has recently been proposed as alternate target for pyrazinoic acid (POA). The results show a low association of PZA resistance and pncA gene mutations in a selected patient group from an highly endemic area. Our findings point out that the phenotypic susceptibility testing remains important for the detection of PZA-resistant M. tuberculosis.
dc.languageENG
dc.rightsArchived with thanks to Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseasesen_GB
dc.titleMycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
dc.typeArticleen
dc.contributor.departmentDepartment of Genome Analytics, Helmholtz Centre for Infection Research, Braunschweig, Germany.en_GB
dc.identifier.journalInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseasesen_GB
refterms.dateFOA2018-06-12T16:42:39Z
html.description.abstractIt has been widely accepted, that pyrazinamide (PZA) resistance in Mycobacterium tuberculosis is correlated with mutations in the pncA gene. But since years researchers have been puzzled by the fact that up to 30% of PZA resistant strains do not show any correlation between PZA resistance and mutations in the pncA gene, and thus may vary with geographic area. The objective of the study was to investigate the correlation between PZA susceptibility and mutations in pncA gene in M. tuberculosis isolates from individuals living in a highly endemic area. Therefore we analyzed drug resistant and multidrug resistant (MDR) isolates from patients in Rio de Janeiro, Brazil. From a total of 97 clinical isolates of M. tuberculosis 35 were identified as PZA resistant, 24/35 strains did not show PZase activity and 15/24 (62.5%) strains possess mutation in the pncA gene. This is a low correlation between PZA resistance and PZase activity (68.6%) and even lower correlation between PZA resistance and the presence of mutation in pncA gene (45.7%). Most of the mutations found were conserved near the active site or metal binding site of PZase. The 146A>C mutation was found both in PZA resistant and susceptible isolates, suggesting that this mutation may not fully associated with PZA resistance. Of the mutations found, three have not been previously described. The insertions 192-193 TCCTCGTC and 388-389 AGGTCGATG, although found before, here was found to be a short tandem repeat and in one strain, insertion of the IS6110 was observed 55nt upstream of the gene. All PZA resistant isolates had no mutation in the gene coding ribosomal protein S1 (rpsA), which has recently been proposed as alternate target for pyrazinoic acid (POA). The results show a low association of PZA resistance and pncA gene mutations in a selected patient group from an highly endemic area. Our findings point out that the phenotypic susceptibility testing remains important for the detection of PZA-resistant M. tuberculosis.


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Bhuju et al_final.pdf
Size:
253.5Kb
Format:
PDF
Description:
original manuscript

This item appears in the following Collection(s)

Show simple item record